Top Markets
Coin of the day
Hancock Jaffe Laboratories Hancock Jaffe Laboratories

Hancock Jaffe Laboratories

HJLI
Kedudukan dalam Saham #35033
Hancock Jaffe Laboratories, Inc. is a medical device company in its... Hancock Jaffe Laboratories, Inc. is a medical device company in its developmental stage, specializing in creating advanced tissue-based and biologic solutions. These innovations are engineered to either sustain or significantly enhance the lives of patients afflicted with cardiovascular, peripheral arterial, and venous diseases, as well as end-stage renal disease (ESRD). The firm, headquartered in Irvine, California, maintains a dedicated team of nine full-time employees. Among its key initiatives, the company is actively developing implantable bioprosthetic devices for cardiovascular applications. This includes the Bioprosthetic Heart Valve (BHV), a swine-derived heart valve designed to mimic the function of a native heart valve and provide superior performance compared to current prosthetic options. Furthermore, the company is developing a Venous Valve, another bioprosthetic device sourced from pig tissue. This valve is specifically designed for individuals suffering from chronic venous insufficiency (CVI) in the lower limbs, a condition frequently resulting from damage to leg vein valves after the formation of deep venous blood clots.
Harga Saham
$10.38
Disegerakkan terakhir: 2021-09-30
Modal Pasaran
$4.55M
Perubahan (1 hari)
-1.98%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Hancock Jaffe Laboratories (HJLI)

Kategori

EPS untuk Hancock Jaffe Laboratories (HJLI)
EPS setakat 2026 TTM: 0
Menurut laporan kewangan terkini dan harga saham Hancock Jaffe Laboratories, EPS semasa syarikat (TTM) adalah 0. Pada akhir tahun 2026, syarikat mempunyai EPS sebanyak 0 sama dengan EPS tahun 2026 iaitu 0.
Sejarah EPS untuk Hancock Jaffe Laboratories dari 2026 hingga 2026
EPS pada akhir setiap tahun
Tahun EPS Ubah
Tidak cukup data untuk tarikh yang disediakan.
EPS untuk syarikat atau pesaing yang serupa